A groundbreaking clinical trial is underway in the UK for LungVax, an experimental vaccine designed to prevent lung cancer. This innovative approach trains the immune system to identify and eliminate early abnormal lung cells before they become tumours. Researchers are hopeful this preventative measure could significantly reduce lung cancer incidence and improve survival rates for those at high risk.
Related Posts
Delhi launches nutrition drive: 6,000+ covered; students drive effort
A newly launched school nutrition education programme in Delhi is set to benefit over 6,000 people, including 1,500 children. Implemented across six schools, it integrates […]
AI race heats up: Elon Musk has ‘good words’ for Google
Elon Musk, the founder of xAI, has surprisingly lauded Google’s dominance in the AI field, citing its significant compute and data advantages. This acknowledgment comes […]
Is Sanju Samson the weakest link in India’s middle order?
Sanju Samson scored a scratchy 45-ball 56 on a sluggish Abu Dhabi pitch against Oman and looked all at sea during his 17-ball stay at […]